Correlation Between Zentalis PharmaceuticalsL and Portage Biotech

Can any of the company-specific risk be diversified away by investing in both Zentalis PharmaceuticalsL and Portage Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zentalis PharmaceuticalsL and Portage Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Zentalis PharmaceuticalsLlc and Portage Biotech, you can compare the effects of market volatilities on Zentalis PharmaceuticalsL and Portage Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zentalis PharmaceuticalsL with a short position of Portage Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zentalis PharmaceuticalsL and Portage Biotech.

Diversification Opportunities for Zentalis PharmaceuticalsL and Portage Biotech

0.88

Correlation Coefficient

Zentalis PharmaceuticalsL  Portage Biotech

Very poor diversification

The 3 months correlation between Zentalis and Portage is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Zentalis PharmaceuticalsLlc and Portage Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Portage Biotech and Zentalis PharmaceuticalsL is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zentalis PharmaceuticalsLlc are associated (or correlated) with Portage Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Portage Biotech has no effect on the direction of Zentalis PharmaceuticalsL i.e., Zentalis PharmaceuticalsL and Portage Biotech go up and down completely randomly.

Pair Corralation between Zentalis PharmaceuticalsL and Portage Biotech

Given the investment horizon of 90 days Zentalis PharmaceuticalsLlc is expected to under-perform the Portage Biotech. But the stock apears to be less risky and, when comparing its historical volatility, Zentalis PharmaceuticalsLlc is 2.3 times less risky than Portage Biotech. The stock trades about -0.01 of its potential returns per unit of risk. The Portage Biotech is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  26.00  in Portage Biotech on February 28, 2024 and sell it today you would earn a total of  0.00  from holding Portage Biotech or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Zentalis PharmaceuticalsLlc  vs.  Portage Biotech

Zentalis PharmaceuticalsL

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Zentalis PharmaceuticalsLlc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in June 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Portage Biotech

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Portage Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in June 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Zentalis PharmaceuticalsL and Portage Biotech

The main advantage of trading using opposite Zentalis PharmaceuticalsL and Portage Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zentalis PharmaceuticalsL position performs unexpectedly, Portage Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Portage Biotech will offset losses from the drop in Portage Biotech's long position.

The idea behind Zentalis PharmaceuticalsLlc and Portage Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.